Roche sees high single-digit core profit growth in 2025
By Thomson ReutersJan 30, 2025 | 12:07 AM
By Ludwig Burger
FRANKFURT (Reuters) – Swiss drugs and diagnostics company Roche said on Thursday it is targeting an increase in core 2025 earnings per share in a high single-digit percentage range, when adjusted for currency swings.
(Reporting by Ludwig Burger, Editing by Rachel More)
For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at 715-842-1672.